Panduan definitif tentang penyuntingan gen.
Menu
Beranda Pelajari Berita Tanya Atlas
Jelajahi Teknologi Penyakit Perawatan Uji Klinis Perusahaan Ilmuwan Gen-gen Penelitian Institusi
Di luar dunia medis Pertanian Etika Investasi Peta dunia
Pelajari & Alat Mulai di sini Glosarium A–Z Bandingkan teknologi Linimasa Daftar & Peringkat Agen AI ★ Tersimpan API
Tentang Tentang kami Metodologi Sumber Data Kebijakan Editorial Kontak Penafian

🧭 Tampilan Terpandu
Baru mengenal genetika? Kami menjelaskan setiap istilah saat kamu menjelajah, dalam bahasa yang mudah dipahami. Halaman yang sama, dengan bantuan yang sudah tersedia.

⚡ Pandangan Ahli
Kamu sudah mengenal biologinya. Cukup kontennya — ringkas dan padat, tanpa penjelasan tambahan. Ini adalah tampilan default.

Bahasa antarmuka
Mode terang

Treatments

Approved Gene-Editing Therapies

Every gene-editing medicine that a national regulator has authorised, worldwide.

Bagaimana daftar ini dibuat

This list is deliberately short, and its shortness is the point. Enormous scientific progress has so far produced a very small number of approved editing medicines. Everything else on this site that sounds promising is research.

#EntriKategori Status
1 Casgevy (exagamglogene autotemcel) The first CRISPR-based medicine approved anywhere in the world — a one-time therapy made… Sickle cell disease; beta thalassemia Approved
2 Lyfgenia (lovotibeglogene autotemcel) Approved on the same day as Casgevy for sickle cell disease — but a gene-addition… Sickle cell disease Approved
3 Zynteglo (betibeglogene autotemcel) An approved gene-addition therapy for transfusion-dependent beta thalassemia — the… Beta thalassemia Approved
Apa yang tidak diberitahu daftar ini kepadamuApproval is country-specific and does not mean a treatment is available, affordable or suitable for any individual. This list includes gene-addition therapies where they are approved for the same conditions, clearly labelled, because the distinction is the point.
Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026